Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 541021 - 541040 out of 553697 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (B02BX06) emicizumab (adm: P) | HEMLIBRA 60MG INJ,SOLN | 0.4 ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Hemophilia A | GenentechUSA,Inc. |
| USA | (B02BX06) emicizumab (adm: P) | HEMLIBRA 60MG INJ,SOLN | 0.4 ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Hemophilia A | GenentechUSA,Inc. |
| USA | (B02BX06) emicizumab (adm: P) | HEMLIBRA 30MG/ML INJ,SOLN | 1ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Hemophilia A | GenentechUSA,Inc. |
| USA | (B02BX06) emicizumab (adm: P) | HEMLIBRA 30MG/ML INJ,SOLN | 1ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Hemophilia A | GenentechUSA,Inc. |
| USA | (B02BX06) emicizumab (adm: P) | HEMLIBRA 30MG/ML INJ,SOLN,0.4ML | 0.4ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Hemophilia A | GenentechUSA,Inc. |
| USA | (B02BX06) emicizumab (adm: P) | HEMLIBRA 30MG/ML INJ,SOLN,0.4ML | 0.4ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Hemophilia A | GenentechUSA,Inc. |
| USA | (B02BX07) lusutrombopag | MULPLETA 3MG TAB | 7 | Ex-factory price without vat |
$0-0 |
$0-0 |
Thrombocytopenia | ShionogiInc. |
| USA | (B02BX07) lusutrombopag | MULPLETA 3MG TAB | 7 | Ex-factory price without vat |
$0-0 |
$0-0 |
Thrombocytopenia | ShionogiInc. |
| USA | (B02BX08) avatrombopag (adm: O) | DOPTELET 20MG TAB | 10 | Ex-factory price without vat |
$0-0 |
$0-0 |
Thrombocytopenia | Sobi,Inc. |
| USA | (B02BX08) avatrombopag (adm: O) | DOPTELET 20MG TAB | 15 | Ex-factory price without vat |
$0-0 |
$0-0 |
Thrombocytopenia | Sobi,Inc. |
| USA | (B02BX08) avatrombopag (adm: O) | DOPTELET 20MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Thrombocytopenia | Sobi,Inc. |
| USA | (B02BX08) avatrombopag (adm: O) | DOPTELET 20MG TAB | 10 | Ex-factory price without vat |
$0-0 |
$0-0 |
Thrombocytopenia | Sobi,Inc. |
| USA | (B02BX08) avatrombopag (adm: O) | DOPTELET 20MG TAB | 15 | Ex-factory price without vat |
$0-0 |
$0-0 |
Thrombocytopenia | Sobi,Inc. |
| USA | (B02BX08) avatrombopag (adm: O) | DOPTELET 20MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Thrombocytopenia | Sobi,Inc. |
| USA | (B02BX09) fostamatinib (adm: O) | TAVALISSE 100MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Thrombocytopenia | RigelPharmaceuticals,Inc. |
| USA | (B02BX09) fostamatinib (adm: O) | TAVALISSE 100MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Thrombocytopenia | RigelPharmaceuticals,Inc. |
| USA | (B02BX09) fostamatinib (adm: O) | TAVALISSE 150MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Thrombocytopenia | RigelPharmaceuticals,Inc. |
| USA | (B02BX09) fostamatinib (adm: O) | TAVALISSE 150MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Thrombocytopenia | RigelPharmaceuticals,Inc. |
| USA | (B02BX11) marstacimab | HYMPAVZI 150MG/ML INJ,SOLN PEN,1ML | 1ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Hemophilia A;Hemophilia B | PfizerInc. |
| USA | (B02BX11) marstacimab | HYMPAVZI 150MG/ML INJ,SOLN PEN,1ML | 1ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Hemophilia A;Hemophilia B | PfizerInc. |
Pages
